Clinical Trial Update: A Study of Sintilimab Combined With Chemotherapy for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is studying sintilimab in combination with chemotherapy as neoadjuvant treatment for esophageal squamous cell carcinoma. The study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING